Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 15, 2017 12:13 ET | Source: ALK Abello

Annual General Meeting in ALK-Abelló A/S held on 15 March 2017

Copenhagen, 2017-03-15 17:13 CET (GLOBE NEWSWIRE) -- ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) held its annual general meeting on 15 March 2017. The annual general meeting...
March 07, 2017 09:43 ET | Source: ALK Abello

Indberetning af ledelsens transaktioner med ALK-Abelló A/S' B-aktier og tilknyttede værdipapirer

København, 2017-03-07 15:43 CET (GLOBE NEWSWIRE) -- ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) indberetter hermed følgende transaktioner: 1. Nærmere oplysninger om...
March 07, 2017 09:43 ET | Source: ALK Abello

Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff

Copenhagen, 2017-03-07 15:43 CET (GLOBE NEWSWIRE) -- ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) reports the following transactions: 1. Details of the person discharging...
March 06, 2017 09:56 ET | Source: ALK Abello

Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff

Copenhagen, 2017-03-06 15:56 CET (GLOBE NEWSWIRE) -- ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) reports the following transactions: 1. Details of the person...
March 06, 2017 09:56 ET | Source: ALK Abello

Indberetning af ledelsens transaktioner med ALK-Abelló A/S' B-aktier og tilknyttede værdipapirer

København, 2017-03-06 15:56 CET (GLOBE NEWSWIRE) -- ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) indberetter hermed følgende transaktioner: 1. Nærmere...
March 03, 2017 03:48 ET | Source: ALK Abello

ALK appoints SVP of R&D for North America and International Markets

Copenhagen, 2017-03-03 09:48 CET (GLOBE NEWSWIRE) -- ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) today announced the appointment of Hendrik Nolte, M.D., Med.Sc.D, as Senior Vice President of...
March 03, 2017 03:48 ET | Source: ALK Abello

ALK udnævner Senior Vice President for R&D i Nordamerika og Internationale markeder

København, 2017-03-03 09:48 CET (GLOBE NEWSWIRE) -- ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) meddeler i dag, at Hendrik Nolte, M.D., Med.Sc.D er udnævnt til ny Senior Vice President for...
March 01, 2017 17:02 ET | Source: ALK Abello

FDA godkender ALKs tabletvaccine mod husstøvmideallergi (ACARIZAX® i Europa)

København, 2017-03-01 23:02 CET (GLOBE NEWSWIRE) -- ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) meddeler i dag, at de amerikanske sundhedsmyndigheder FDA har godkendt...
March 01, 2017 17:02 ET | Source: ALK Abello

ALK announces FDA approval for its house dust mite sublingual allergy immunotherapy tablet (ACARIZAX® in Europe)

Copenhagen, 2017-03-01 23:02 CET (GLOBE NEWSWIRE) -- ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) today announced that the US Food and Drug Administration (FDA) has approved the...
February 27, 2017 09:12 ET | Source: ALK Abello

ALK’s ACARIZAX® data results in significant change to the GINA asthma management strategy: Sublingual allergy immunotherapy (SLIT) recommended as a treatment option in patients with house dust mite allergic asthma

Copenhagen, 2017-02-27 15:12 CET (GLOBE NEWSWIRE) -- ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) today announced that for the first time, allergy immunotherapy is now recommended as a...